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To study the clinical presentation, hospital course and outcomes of patients 
admitted with Guillain-Barre Syndrome (GBS) to three tertiary care hospitals in 
Mashhad, Iran.
Materials and Methods
The records of all patients admitted with flaccid paralysis between April 1999 
and January 2005 were reviewed and those with the diagnosis of GBS were 
included in the study. Standard questionnaires were used to record clinical data 
on was recorded on a standardized questionnaire, which included patients’ 
age, sex, antecedent infectious history, neurological signs and symptoms and 
ventilation requirements. The hospital course, including therapy given and the 
functional status of patients, was analyzed, including therapy given and the 
functional status of patients.
Results
Ninety-one cases of acute flaccid paralysis were admitted to the hospitals during 
the study period. Eighty-three cases, age range 10 months to 11 years, were later 
diagnosed as GBS afterwards, with an age range of 10 months to 11 years. The 
mean age for disease onset was 4.2 years; there were 47 boys and 34 girls, male 
to female ratio 1:0.7. Upper respiratory tract infection (62.6%) was the most 
common antecedent event, followed by gastrointestinal infections (19%), urinary 
tract infection (1.2%) and chicken pox (2.4%), while the remaining cases (14.8%) 
had no other cases (14.8%) did not have any reliable history of any preceding 
antecedent infections. Most patients developed GBS within one month of the 
preceding infection. Cranial nerve abnormalities (19.3%), autonomic dysfunction 
(7.2%) and respiratory failure requiring intubation (10.8%) were also common. 
The in-patient mortality was 2.4% (2 of 83).
Conclusion
GBS was found to occur slightly more often in male patients, majority of whom 
had histories of previous infection. Despite persistent disability, in-hospital 
mortality was low.




Guillain-Barré Syndrome (GBS) is the leading cause of acute neuromuscular 
weakness in the developed world (1). Different terminologies e.g. acute inflammatory 
demyelinating polyneuropathy (AIDP), acute motor axonal neuropathy (AMAN), 
acute motor-sensory axonal neuropathy (AMSAN) and Miller Fisher Syndrome, 
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are all included under the GBS rubric (2). GBS leads to a 
wide variety of deficits, characterized by rapidly evolving, 
symmetrical and often ascending limb weakness, loss 
of deep tendon reflexes, variable sensory signs and 
autonomic dysfunction (3). Occurring worldwide, it 
affects people of all ages and both sexes. Studies on 
patients with GBS indicate that the disease is the result 
of aberrant immune responses against components of 
peripheral nerves. The exact etiology of Guillain-Barré 
Syndrome remains elusive and incompletely defined. It 
is generally considered to be a post-infectious disease, 
with almost two-thirds of patients reporting an infectious 
illness prior to the onset of GBS symptoms (4).
The purpose of this study was to review and investigate 
the clinical course and outcome of patients with Guillain-
Barré Syndrome admitted to our hospital over a 6-year 
period from 1999 to 2005. Special emphasis was laid on 
the characteristics of clinical and laboratory conditions 
and the complications which developed during their 
hospital stay. Symptoms at time of admission and on the 
60th day of presentation were compared and analyzed.
 
Patients and Methods
The study was carried out at the Qaem, Imam Reza 
and Dr. Sheikh Hospitals of Mashhad University of 
medical sciences over a 6-year period (from 1999 to 
2005). Of ninety-one cases of acute flaccid paralysis 
admitted in these hospitals, 83 patients were diagnosed 
with Guillain-Barré Syndrome, the diagnosis being 
confirmed on the basis of clinical presentation, CSF 
findings, electromyography and nerve conduction 
studies. A structured questionnaire was designed which 
documented age of the patient, antecedent history of 
infection, neurologic dysfunction, admission in intensive 
care unit (ICU) and the duration of hospital stay. Patient’s 
records also included complications during hospital 
stay, management, and the treatment given. Using the 
Modified Rankin Scale, patient symptoms at time of 
admission and again degree of disability on the 60th day 
following presentation by Modified Rankin Scale(5). All 
information was coded to retain patient confidentiality. 
Data collected was entered and analyzed using SPSS 
11.5.
Results
The study included 83 GBS patients, mean age 4.2 years 
(range 10 months to 11 years); 47 (56.6%) were male, 
and the male to female ratio was 1: 0.7.  
Seventy (84.3%) patients reported a history of infection 
having occurred within the month prior to onset of 
GBS; of infections reported, upper respiratory tract 
infection was the most common (62.6%), followed 
by gastrointestinal infections (19.0%), chicken pox 
(2.4%) and urinary tract infection (1.2%); remaining 
cases however had no histories of prior infection. Sixty 
nine (83.1%) patients had the initial symptoms of limb 
weakness and ataxia, the inability to walk; 14 (16.9%) 
patients had four limb weakness. Another universal 
finding seen during the course of illness was absence of 
or reduced deep tendon reflexes (DTR); 48 (57.8%) had 
decreased DTR, in 23(27.7%) no DTR was detected, and 
12 (14.5%) patients had normal DTR. Thirty-nine (42%) 
patients had cranial nerve involvement including ptosis, 
gaze problems, nystagmus and facial nerve paralysis and 
gag reflex dysfunction. Twenty eight (33.7%) patients 
were admitted in ICU because of severe illness. Sensory 
disturbance (pain, and paresthesis) was seen in 54 
(65.1%) of our patients  (Table 1).
Table1. Clinical features in 83 patients with GBS.
Clinical features Frequency %
Sensory disturbance 54 65.1
Cranial  nerve involvement 39     42
Respiratory distress 16 19.3




ICU admission 28 33.7
Decreased DTR 48 57.8
No DTR 23 27.7
Electroneurography
Axonal variant 17 20.5
Not characteristic 4 4.8
Demyelinating variant 62 74.7
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The electromyographic and nerve conduction studies 
(60/83 patients) in the first week of the GBS (mean ± 
S.D. = 5.3 ± 2 days) showed that the demyelinating 
type of neuropathy was the predominant form of GBS 
in our patients. Lumbar puncture was done an average 
8 days after the beginning of paralysis. Raised protein 
levels in cerebrospinal fluid (CSF) were seen in 19 
(22.9%) patients while 27 (35.5%) had normal values; 
37 (44.6%) patients refused to undergo lumbar puncture 
(LP). The average duration of stay in hospital was 8.7 
days (range 1 to 23 days). The most common condition 
seen, 16(57.1%) of 28 ICU admitted cases, requiring ICU 
admission was respiratory distress; 9(10.8%) patients 
had to be intubated for respiratory failure. A majority 
of patients exhibited a good recovery within sixty 
days following the initiation of symptoms. In addition 
to supportive care, 2 patients (2.4%) were managed 
with plasmapheresis, 46 (55.4%) received intravenous 
immunoglobulin (IVIG), and 1 (1.2%) received methyl 
prednisolone. Nine patients (10.8%) received IVIg and 
methyl prednisolone. Nine patients (10.8%) were treated 
with IVIg and Plasmapheresis. Two patients (2.4%) 
were treated with all the three therapies (IVIG, methyl 
prednisolone and plasmapheresis). Fourteen patients 
received supportive care per se and were not given any 
drugs. Six (7.2%) patients, received anti hypertensive 
drugs besides other drugs. Two patients (2.4%) died of 
cardiac arrest while they were admitted in hospital.
As all the cases were admitted with acute flaccid paralysis, 
their condition on day 60 was studied; the median Rankin 
score, which at admission was 4.5, at discharge had 
decreased to 3. Results showed that 59 cases (73%) had 
no remaining paralysis, whereas 22(27%) still had some 




Guillain-Barré Syndrome (GBS) is a relatively 
common cause of neuromuscular weakness (1, 3-10). 
Unfortunately, there is a paucity of published information 
on the local incidence of the condition. 
In the current study, we collected data on GBS patients 
admitted to the hospitals mentioned between 1999 and 
2005.  The male to female ratio of 1:0.72 in our patients 
was similar to that cited in other studies (2, 6-10).
Most studies showed an antecedent history of infection 
in 50 to 71% of patients with GBS (2, 6-8). Our findings 
showed a higher incidence (84.3%) of antecedent history 
of infection. In most studies, non-specific upper respiratory 
tract infection was the most common preceding event (2, 
6-9), similar to the findings of our study. 
In our study, cranial nerve involvement was seen in 
19.2% of patients, which differs from that reported by 
Cheng (7), Mckhann (8) and Rong-Kuo Lyu (9). None 
of our patients had confusion or signs and symptoms 
suggestive of encephalopathy.
The average duration of hospital stay in our patients 
was 8.7 days (range 1 to 23 days), comparable to that 
previously reported and relevant to pathologic type of 
GBS (11,12).
Occurrence of hypertension as part of autonomic 
dysfunction was seen in six patients, higher than that 
reported in another study (13). 
The percentage of patients requiring ventilatory assistance 
was lower in our study (10.8%) as compared to those 
between 21% to 43.1% reported in literature (3,4,6).
Most of our patients had started recovering at the time 
of discharge. Our patients had a median Rankin score 
of 4.5 at initial admission; this may be because of late 
presentation, late recognition or rapid progression of 
disease. The disease itself may be more severe and/or 
rapidly progressive in our population. The mortality in 
our series is low (2.4%), which is comparable with rates 
of other series (10,11,12). 
Most of our patients had demyelinating neuropathy. 
All our patients who had prolonged recovery had either 
axonal or undifferentiated Guillain-Barré syndrome 
(EMG had been suspicious and could not detect any 
form of GBS). These results indicate that Guillain-Barré 
syndrome is a disease with a good prognosis in patients 
who survive the acute stage(9,14-17).
Regarding the small number of patients treated with 
steroids or combination of IVIg and Plasmapheresis or 
IVIg and steroids, we were unable to draw any definite 
conclusion regarding methods of treatment.
Conclusion
In conclusion, GBS was seen in all the pediatric age 
groups, with a majority of patients having a history of 
previous infections. Rapid progression, mild disease, 
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lesser need for ventilation and slow recovery were seen 
in most patients. Inpatient mortality was low and severe 
disease on presentation followed by protracted recovery 
was not associated with poor outcome.
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